Central Venous Catheters (CVCs) Market Size, Growth Opportunities, and Forecast to 2035

The global Central Venous Catheters (CVCs) Market is on a steady growth path, valued at USD 1.5 billion in 2025 and projected to reach USD 2.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.0%. This growth is fueled by the rising prevalence of chronic diseases such as cancer and kidney failure, increasing surgical procedures, and advancements in catheter technology. Central venous catheters are critical medical devices used for administering medications, fluids, nutrients, and monitoring hemodynamic status in critical care, oncology, and long-term treatment settings. The market’s expansion is further supported by the growing geriatric population and the increasing demand for minimally invasive procedures.

The significance of this market lies in its essential role in modern healthcare, particularly for patients requiring long-term intravenous access. With an estimated 19.3 million new cancer cases globally in 2020 and chronic kidney disease affecting approximately 10% of the world’s population, CVCs are vital for delivering therapies like chemotherapy, dialysis, and parenteral nutrition. The market has also been shaped by the need for rapid vascular access during emergencies, as seen during the COVID-19 pandemic, which highlighted the importance of CVCs in intensive care units (ICUs).

For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=central-venous-catheters-cvcs-market

Market Analysis

The central venous catheters market is driven by the increasing incidence of chronic diseases, technological advancements, and the expansion of healthcare infrastructure. The global rise in cancer, cardiovascular diseases, and renal disorders—coupled with an aging population projected to reach 2.1 billion over 60 by 2050—fuels demand for CVCs in long-term therapies. Innovations like antimicrobial-coated catheters and ultrasound-guided insertion techniques have reduced complications like catheter-related bloodstream infections (CRBSIs), enhancing adoption. The growing number of surgical procedures, particularly in oncology and critical care, further boosts demand, with approximately 5 million CVCs used annually in the U.S. alone.

However, challenges persist. CRBSIs, which account for 90% of catheter-related infections, remain a significant concern, leading to prolonged hospitalizations and increased costs. Stringent regulatory requirements for safety and efficacy, such as FDA and CE Mark approvals, increase production costs and create barriers for new entrants. The high cost of advanced CVCs and the growing popularity of alternative devices like peripherally inserted central catheters (PICCs) also limit market growth. Additionally, mechanical complications like thrombosis and device malfunctions require ongoing innovation to address.

Segment Analysis

The central venous catheters market is segmented by product type, design, material, application, and end-user. By product type, non-tunneled catheters dominate due to their widespread use in emergency and critical care settings, while tunneled catheters are preferred for long-term treatments like dialysis. By design, multi-lumen catheters hold over 50% market share, driven by their ability to administer multiple therapies simultaneously, reducing insertion frequency. Polyurethane dominates the material segment for its durability, while silicone is favored for its flexibility in tunneled catheters. By application, oncology leads due to the high demand for chemotherapy, followed by critical care and dialysis. Hospitals are the primary end-users, driven by high procedure volumes, followed by ambulatory surgical centers and home healthcare settings.

Country-wise Insights

In the United States, the CVC market is valued at USD 0.5 billion in 2025, with a projected CAGR of 6.4% through 2035, driven by advanced healthcare infrastructure and high prevalence of chronic diseases. The U.S. accounts for over 34% of the global market, with 5 million CVCs used annually. In the United Kingdom, the market is expected to grow at a CAGR of 5.8%, reaching USD 0.1 billion by 2035, supported by an aging population and NHS investments in critical care. In China, the market is forecasted to grow at a CAGR of 7.7%, reaching USD 0.3 billion by 2035, fueled by healthcare modernization and a rising burden of chronic diseases.

Key Players

• Becton, Dickinson and Company (BD)
• Teleflex Incorporated
• B. Braun SE
• AngioDynamics
• Smiths Medical (ICU Medical, Inc.)
• COOK MEDICAL LLC
• Medtronic Plc

Strategic Outlook and Industry Trends

The central venous catheters market is evolving with a focus on safety, innovation, and accessibility. Antimicrobial-coated catheters are gaining traction to reduce CRBSIs, while advancements like tip location devices and ultrasound guidance improve placement accuracy and patient outcomes. The rise of minimally invasive procedures and home healthcare is creating demand for portable, user-friendly CVCs. Manufacturers are investing in biocompatible materials and smart sensors for real-time monitoring to enhance safety. Strategic partnerships and acquisitions, such as BD’s expansion of its vascular access portfolio, are strengthening market presence. Emerging markets in Asia-Pacific and Latin America offer significant growth potential due to expanding healthcare access. However, companies must address infection risks, regulatory hurdles, and competition from PICCs to remain competitive.

Segmentation of Central Venous Catheters (CVCs) Market

• By Product Type:
• Tunneled Catheters
• Non-Tunneled Catheters
• Implanted Ports
• Peripherally Inserted Central Catheters (PICCs)
• By Design:
• Single-Lumen
• Double-Lumen
• Triple-Lumen
• Multi-Lumen
• By Material:
• Polyurethane
• Silicone
• Others
• By Application:
• Oncology
• Critical Care
• Dialysis
• Parenteral Nutrition
• Others
• By End-User:
• Hospitals
• Ambulatory Surgical Centers
• Long-Term Care Facilities
• Home Healthcare
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com